Alkermes Plc (ALKS)
47.08
-0.64
(-1.34%)
USD |
NASDAQ |
Sep 03, 13:41
Alkermes Research and Development Expense (Annual) : 318.36M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 318.36M |
| December 31, 2024 | 239.63M |
| December 31, 2023 | 261.21M |
| December 31, 2022 | 262.00M |
| December 31, 2021 | 394.33M |
| December 31, 2020 | 379.49M |
| December 31, 2019 | 412.23M |
| December 31, 2018 | 413.51M |
| December 31, 2017 | 402.39M |
| December 31, 2016 | 379.25M |
| December 31, 2015 | 338.20M |
| December 31, 2014 | 263.84M |
| December 31, 2013 | 162.70M |
| March 31, 2012 | 141.89M |
| March 31, 2011 | 97.24M |
| March 31, 2010 | 95.36M |
| March 31, 2009 | 89.48M |
| Date | Value |
|---|---|
| March 31, 2008 | 125.27M |
| March 31, 2007 | 117.32M |
| March 31, 2006 | 87.87M |
| March 31, 2005 | 88.76M |
| March 31, 2004 | 91.10M |
| March 31, 2003 | 76.07M |
| March 31, 2002 | |
| March 31, 2001 | 68.77M |
| March 31, 2000 | |
| March 31, 1999 | 43.07M |
| March 31, 1998 | 28.78M |
| March 31, 1997 | 27.20M |
| March 31, 1996 | 19.82M |
| March 31, 1995 | 17.53M |
| March 31, 1994 | 19.22M |
| March 31, 1993 | 16.08M |
| March 31, 1992 | 6.368M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amarin Corp. Plc | 16.82M |
| Jazz Pharmaceuticals Plc | 782.74M |
| Prothena Corp. Plc | 134.85M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Biogen, Inc. | 1.481B |